Ngokuvamile, ekwelapheni isibindi nesilonda se-pathologies yezinyosi, izidakamizwa ze-hepatoprotective ezisuselwa ku-bile ursodeoxycholic acid zisetshenziselwa njengengxenye yokwelashwa okuyinkimbinkimbi. Le mithi ihlanganisa izifanekiselo zase-Urdoks nase-Ursosan, odokotela abangakwazi ukuwabeka ekukhethweni kwesiguli (nezinye izidakamizwa ezifanayo zingase zinconywe). Iziguli eziningi, eziya ekhemisi, zibuzwa okungcono - i-Urdoksa noma i-Ursosan, nokuthi yiziphi izidakamizwa ezithandayo. Ake sicabangele, kungakhathaliseki ukuthi kukhona umehluko emalungiselelweni anikeziwe, futhi sizokwazi kabanzi ngokuningiliziwe ngezici zabo.
Ukufana nokuhluka kwezidakamizwa u-Urdoksa ne-Ursosan
Bobabili i-Urdoksa ne-Ursosan zitholakala ngesimo samaphissili agcwele i-gelatin. Okuqukethwe kwezinto ezisebenzayo (i-ursodeoxycholic acid) kuzo futhi kuyafana nokuthi ngu-250 mg. Ukwakhiwa kwe-Urdoksa ne-Ursosan akufani neze ngokuphathelene nezinsimbi ezisizayo, uhlu olulandelayo:
- isitashi;
- i-silicon dioxide colloidal;
- i-magnesium stearate.
Yilokho, eqinisweni, u-Urdoksa no-Ursosan - kuyinto efanayo.
Umehluko phakathi kwalezi zidakamizwa ukhona kubakhiqizi bawo, kanye nezindleko ezihambisanayo. I-Ursosan ikhiqizwa inkampani yezokwelapha yaseCzech, futhi umenzi we-Urdoksa yiRussia. Intengo yemithi yasekhaya ihle kancane. Kumele kuqashelwe ukuthi zonke izithako ezidingekayo ze-Urdoksi zithengwa phesheya, ngakho-ke zinezici ezifanayo ezifana ne-Ursosan (isibonelo, ngezinga lokuhlanzwa kwama-chemical compounds).
Umphumela wokwelapha wase-Urdoksy no-Ursosana
Isenzo semithi yezokwelapha zombili lezi zidakamizwa sichazwa ngethonya lesithako esisebenzayo, okuthi emva kokuhlanganiswa emaseli we-hepatocytes, sinomphumela olandelayo:
- ukuxoshwa kwe-bile acids;
- ukwehla ekugculeni kwe-bile nge-cholesterol;
- i-normalization ye-bile igeleza ngaphakathi kwe-duodenum;
- ukuchithwa kwamatshe e-cholesterol ku-gallbladder nokuvimbela ukwakheka kwezithako ezintsha;
- isinyathelo sokuqondisa okuzenzakalelayo;
- ukuvuselelwa kwesakhiwo se-membrane yeseli ye-hepatocytes;
- umphumela wokulwa nokuvuvukala;
- ukwandisa umphumela wama-antiviral agents;
- kuvimba ukuthuthukiswa kwezicubu ezixhumene nesibindi;
- isenzo se-immunomodulating.
Ngenxa yokuthatha lezi zimali, ubukhulu besifo se-asthenic syndrome sesifo sesibindi, kanye nesifo se-dyspepsia, esilula isikhumba, sinciphise kakhulu. Kukhona nokunciphisa okusheshayo ngobukhulu besifo esibindile besibindi, ukusebenza kwe-synthesis kanye ne-excretion ye-bile.
Izinkomba zokusebenzisa i-Urdoksy ne-Ursosana:
- i- cholelithiasis engaqondakali;
- i-hepatitis engapheli ye-genesis ehlukahlukene;
- i-cirrhosis eyinhloko ye-biliary;
- i-cystic fibrosis;
- isifo sesibindi sesidakwa;
- okungewona utshwala obuthakathaka;
- i-dyskinesia ye-bile ducts, njll.
Isilinganiso semithi, kanye nemvamisa yokuphatha kanye nobude bokusetshenziswa kuyahlukahluka kuye ngokuthi kutholakala yini, izici eziqondene nomzimba kanye nokuqina kwenqubo ye-pathological. Ngokwesilinganiso, umthamo wansuku zonke we-ursodeoxycholic acid ukwelashwa nokuvimbela ama-capsules angu-2-3, kanti isikhathi sokwenza ukwelashwa kungaba
Ukungafani kokuthola ukwakhiwa kwe-Urdoksy ne-Ursosana:
- ukuxilonga kwamalungu ezidakamizwa;
- ama-gallstones aphezulu e-calcium;
- i-gallbladder engasebenzi;
- ukukhubazeka okuphawulekayo komsebenzi wezinyosi, umsebenzi we-hepatic noma we-pancreatic;
- i-cirrhosis yesibindi esigabeni sokuqedela;
- izifo ezinamandla ezithathelwanayo nezokuvuvukala ze-biliary tract, njll.